Value of the CHA2DS2-VASc risk score and modified Fabry-specific scores for predicting new-onset or recurrent stroke/TIA in patients with Fabry disease
Morbi-mortality in hypertrophic cardiomyopathy beyond sudden cardiac death - new clinical, imaging and genetic predictors and integration with novel scores